MR-proADM as prognostic factor of outcome in COVID-19 patients
MR-proADM as prognostic factor of outcome in COVID-19 patients
About this item
Full title
Author / Creator
Sozio, Emanuela , Tascini, Carlo , Fabris, Martina , D’Aurizio, Federica , De Carlo, Chiara , Graziano, Elena , Bassi, Flavio , Sbrana, Francesco , Ripoli, Andrea , Pagotto, Alberto , Giacinta, Alessandro , Gerussi, Valentina , Visentini, Daniela , De Stefanis, Paola , Merelli, Maria , Saeed, Kordo and Curcio, Francesco
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Mid Regional pro-ADM (MR-proADM) is a promising novel biomarker in the evaluation of deteriorating patients and an emergent prognosis factor in patients with sepsis, septic shock and organ failure. It can be induced by bacteria, fungi or viruses. We hypothesized that the assessment of MR-proADM, with or without other inflammatory cytokines, as part...
Alternative Titles
Full title
MR-proADM as prognostic factor of outcome in COVID-19 patients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_a8a013a15cbd41c2a6ba4ba6f7e62b67
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a8a013a15cbd41c2a6ba4ba6f7e62b67
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-021-84478-1
